PTN Stock Summary and Trading Ideas (Palatin Techs | AMEX:PTN)

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.

What symbol and exchange does Palatin Techs shares trade?

Palatin Techs trades on the AMEX stock market under the symbol PTN.

What is Palatin Techs stock price doing today?

As of February 23, 2026, PTN stock price declined to $20.20 with 21,505 million shares trading.

What is Palatin Techs's Beta?

PTN has a beta of -9.95, meaning it tends to be less sensitive to market movements. PTN has a correlation of 0.26 to the broad based SPY ETF.

How much is Palatin Techs worth?

PTN has a market cap of $34.39 million. This is considered a Sub-Micro Cap stock.

How much money does Palatin Techs make?

Last quarter Palatin Techs reported $116,036 in Revenue and -$2.86 earnings per share. This beat revenue expectation by $99,366 and missed earnings estimates by -$1.39.

What are the top ETFs holding Palatin Techs?

The top ETF exchange traded funds that PTN belongs to (by Net Assets): VXF.

What are the support and resistance levels for Palatin Techs (PTN)?

PTN support price is $20.60 and resistance is $24.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PTN shares will trade within this expected range on the day.